Cipla founding family’s stake sale in jeopardy over $13 billion valuation target
CFO News
SEPTEMBER 14, 2023
Prospective buyers of a stake in Indian pharmaceutical company Cipla Ltd. are hesitant due to the high valuation demanded by the founding family. Negotiations have stalled as the family is seeking about 1,350 rupees per share, representing a 10% premium over the current price.
Let's personalize your content